Home Cart 0 Sign in  

[ CAS No. 22246-13-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 22246-13-5
Chemical Structure| 22246-13-5
Structure of 22246-13-5 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 22246-13-5 ]

Related Doc. of [ 22246-13-5 ]

Alternatived Products of [ 22246-13-5 ]
Product Citations

Product Details of [ 22246-13-5 ]

CAS No. :22246-13-5 MDL No. :MFCD00559318
Formula : C9H10N2O Boiling Point : -
Linear Structure Formula :- InChI Key :NFWVCYWFUIFIKU-UHFFFAOYSA-N
M.W : 162.19 Pubchem ID :4912759
Synonyms :

Calculated chemistry of [ 22246-13-5 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 2.0
Molar Refractivity : 50.95
TPSA : 55.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.82 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.25
Log Po/w (XLOGP3) : 0.66
Log Po/w (WLOGP) : 0.59
Log Po/w (MLOGP) : 0.84
Log Po/w (SILICOS-IT) : 1.37
Consensus Log Po/w : 0.94

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.63
Solubility : 3.79 mg/ml ; 0.0234 mol/l
Class : Very soluble
Log S (Ali) : -1.39
Solubility : 6.55 mg/ml ; 0.0404 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.8
Solubility : 0.258 mg/ml ; 0.00159 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.46

Safety of [ 22246-13-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 22246-13-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 22246-13-5 ]

[ 22246-13-5 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 22246-13-5 ]
  • [ 175205-81-9 ]
  • [ 1579950-38-1 ]
  • 2
  • [ 22246-13-5 ]
  • [ 3177-24-0 ]
  • [ 765-30-0 ]
  • 4-(cyclopropylamino)-2-((2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)amino)pyrimidine-5-carbonitrile [ No CAS ]
  • 2-(cyclopropylamino)-4-((2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)amino)pyrimidine-5-carbonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
14 mg; 14 mg Example 287: Preparation of 4-(cyclopropylamino)-2-((2-oxo-l,2,3,4-tetrahydroquinolin-6- yl)amino)pyrimidine-5-carbonitrile and 2-(cyclopropylamino)-4-((2-oxo-l,2,3>4- tetrahydroquinolin-6-yl)amino)pyrimidine-5-carbonitrile.2,4-Dichloropyrimidine-5-carbonitrile (0.100 g, 0.575 mmol), cyclopropanamine (0.040 ml, 0.575 mmol) and N-ethyl-N-isopropylpropan-2-amine (0.1 10 ml, 0.632 mmol) were mixed in acetonitrile (2 ml). The mixture was microwaved at 70 °C for 10 min and then concentrated. 6- amino-3,4-dihydroquinolin-2(l H)-one (0.093 g, 0.575 mmol) and acetic acid (0.035 g, 0.575 mmol) were added. The mixture was microwaved at 1 10 °C for 20 min and then concentrated. 14 mg of 4-(cyclopropylamino)-2-((2-oxo- l ,2,3,4-tetrahydroquinolin-6-yl)amino)pyrimidine-5- carbonitrile and 14 mg of 2-(cyclopropylamino)-4-((2-oxo-l ,2,3,4-tetrahydroquinolin-6- yl)amino)pyrimidine-5-carbonitrile were recovered after automated reverse phasechromatography (water-MeCN). MS calcd for [Ci7Hi6N60+H]+: 321.15 found 321.00.
  • 3
  • [ 22246-13-5 ]
  • [ 475216-25-2 ]
  • N-methyl-3-nitro-4-((2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)amino)benzamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
96% With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; at 80℃; for 72h; To a stirred solution of <strong>[475216-25-2]4-fluoro-N-methyl-3-nitrobenzamide</strong>2 (500 mg) in N-methyl-2- pyrrolidinone (5 ml) were added 6-amino-3,4-dihydroquinolin-2(iH)-one24 (450 mg) and N,Ndiisopropylethylamine (489 mg). The reaction mixture was heated at 80 C for 3 days. LC-MS analysis indicated that the reaction was incomplete. The reaction mixture was heated at 120 Cfor 1 day. The reaction mixture was cooled to room temperature and ethyl acetate (10 ml) and water (3 ml) were added. An orange precipitate formed. The precipitate was collected by filtration, washed with ethyl acetate, and dried in vacuo to give N-methyl-3-nitro-4-((2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)amino)benzamide as an orange solid (825 mg, 96 %). MS (ISP):341.0 ([M+H]j.
  • 4
  • [ 4080-54-0 ]
  • [ 22246-13-5 ]
  • 3-ethyl-N-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)isonicotinamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
88% With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 20℃; for 2h; Into a 40- mL vial was placed a mixture of 6-amino-7-fluoro-3,4-dihydroquinolin-2(lH)-one (180 mg, 1.00 mmol, 1.00 equiv), N,N-dimethylformamide (5 mL), <strong>[4080-54-0]3-ethylisonicotinic acid</strong> (166 mg, 1.10 mmol, 1.10 equiv), N-ethyl-N-isopropylpropan-2-amine (387 mg, 3.00 mmol, 3.00 equiv) and l-((dimethylamino)(dimethyliminio)methyl)-lH-[l,2,3]triazolo[4,5-b]pyridine 3- oxide hexafluorophosphate(V) (570 mg, 1.50 mmol, 1.50 equiv). The reaction mixture was stirred for 2 hours at room temperature. The reaction mixture was filtered and the filtrate was purified by prep-HPLC. This resulted in 260 mg (88%) of 3-ethyl-N-(2-oxo-l,2,3,4- tetrahydroquinolin-6-yl)isonicotinamide. LC-MS (ES) [M+l]+ m/z: 296.1. Tl NMR (DMSO-i, 300 MHz) was consistent with a compound having the structure of 3-ethyl-N-(2- oxo-l,2,3,4-tetrahydroquinolin-6-yl)isonicotinamide.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 22246-13-5 ]

Amides

Chemical Structure| 553-03-7

[ 553-03-7 ]

3,4-Dihydroquinolin-2(1H)-one

Similarity: 1.00

Chemical Structure| 4424-80-0

[ 4424-80-0 ]

4,5-Dihydro-1H-benzo[b]azepin-2(3H)-one

Similarity: 1.00

Chemical Structure| 13220-46-7

[ 13220-46-7 ]

4-Methylindolin-2-one

Similarity: 0.94

Chemical Structure| 56341-38-9

[ 56341-38-9 ]

6-Methyl-2-indolinone

Similarity: 0.92

Chemical Structure| 59-48-3

[ 59-48-3 ]

Indolin-2-one

Similarity: 0.92

Amines

Chemical Structure| 20876-36-2

[ 20876-36-2 ]

5-Aminoindolin-2-one

Similarity: 0.92

Chemical Structure| 150544-04-0

[ 150544-04-0 ]

6-Aminoindolin-2-one

Similarity: 0.91

Chemical Structure| 120266-80-0

[ 120266-80-0 ]

5-Aminoindolin-2-one hydrochloride

Similarity: 0.91

Chemical Structure| 22246-76-0

[ 22246-76-0 ]

8-Amino-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one

Similarity: 0.91

Chemical Structure| 621-06-7

[ 621-06-7 ]

N,2-Diphenylacetamide

Similarity: 0.90

Related Parent Nucleus of
[ 22246-13-5 ]

Tetrahydroquinolines

Chemical Structure| 553-03-7

[ 553-03-7 ]

3,4-Dihydroquinolin-2(1H)-one

Similarity: 1.00

Chemical Structure| 1175358-24-3

[ 1175358-24-3 ]

1'H-Spiro[piperidine-4,3'-quinolin]-2'(4'H)-one hydrochloride

Similarity: 0.89

Chemical Structure| 22246-07-7

[ 22246-07-7 ]

7-Amino-3,4-dihydro-2(1H)-quinolinone

Similarity: 0.89

Chemical Structure| 40615-17-6

[ 40615-17-6 ]

3-Amino-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.88

Chemical Structure| 52851-41-9

[ 52851-41-9 ]

Quinoline-2,4(1H,3H)-dione

Similarity: 0.85

; ;